Intensive first-line FIr-C/FOx-C association of triplet chemotherapy plus cetuximab in RAS wild-type metastatic colorectal cancer patients: preliminary phase II data and prediction of individual limiting toxicity syndromes by pharmacogenomic biomarkers
RAS野生型转移性结直肠癌患者一线强化FIr-C/FOx-C联合三联化疗加西妥昔单抗治疗：初步II期数据及药物基因组学生物标志物对个体限制性毒性综合征的预测
期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/1758835919846421
Bruera, Gemma; Massacese, Silvia; Pepe, Francesco; Malapelle, Umberto; Dal Mas, Antonella; Ciacco, Eugenio; Calvisi, Giuseppe; Troncone, Giancarlo; Simmaco, Maurizio; Ricevuto, Enrico
